José de Chastonay
Treasurer bei European University Foundation
Profil
José de Chastonay is currently the Treasurer at European University Foundation.
Previously, he served as the President & CEO at FUJIFILM Irvine Scientific, Inc., Executive Chairman at New England Peptide, Inc., Director at Viroblock SA and Protein Technologies, Inc., Managing Director at Wombat Capital Ltd., Chief Marketing Officer at Bachem Holding AG, Principal at Ares Serono SA, President & COO at Bachem Bioscience, Inc. and Bachem Americas, Inc., and Manager-International Marketing at Roche Diagnostics AG.
He holds a doctorate from the University of Bern and an MBA from European University Portugal Centro de Estudos de Gestão SA.
Aktive Positionen von José de Chastonay
Unternehmen | Position | Beginn |
---|---|---|
European University Foundation | Treasurer | - |
Ehemalige bekannte Positionen von José de Chastonay
Unternehmen | Position | Ende |
---|---|---|
Wombat Capital Ltd.
Wombat Capital Ltd. Wombat Capital Markets LLC is a registered broker-dealer and member of FINRA and SIPC. The company offers cross-border investment banking and strategic advisory services to the pharmaceutical outsourcing, medical devices, and diagnostics industries. The company is based in New York, NY. | Corporate Officer/Principal | 01.05.2012 |
FUJIFILM Irvine Scientific, Inc.
FUJIFILM Irvine Scientific, Inc. BiotechnologyHealth Technology FUJIFILM Irvine Scientific, Inc. engages in the manufacture and distribution of cell culture media, reagents, and medical devices. It offers bioproduction, assisted reproductive technology, cytogenetics, cell and gene therapy, and classical media. The company was founded in 1970 and is headquartered Santa Ana, CA. | Präsident | 01.01.2009 |
New England Peptide, Inc.
New England Peptide, Inc. Chemicals: Major DiversifiedProcess Industries New England Peptide, Inc. designs and manufactures peptides, polyclonal antibodies, and monoclonal antibodies for drug and vaccine discovery organizations. Its products include TrypTides, bioactive peptides, amino acids and resins, peptide synthesis accessories, ME Kit Exosome isolation, SISCAPA assay reagents, and TrypRaws. The company was founded by Samuel A. Massoni and Jennifer L. Massoni in 1998 and is headquartered in Gardner, MA. | Vorsitzender | - |
Protein Technologies, Inc.
Protein Technologies, Inc. Medical SpecialtiesHealth Technology Protein Technologies, Inc. engages in the design, manufacture and supply of solid phase synthesizers. The company was founded in 1985 and is headquartered in Tucson, AZ. | Direktor/Vorstandsmitglied | - |
Bachem Americas, Inc.
Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA. | Präsident | - |
Ausbildung von José de Chastonay
University of Bern | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BACHEM HOLDING AG | Health Technology |
Private Unternehmen | 12 |
---|---|
FUJIFILM Irvine Scientific, Inc.
FUJIFILM Irvine Scientific, Inc. BiotechnologyHealth Technology FUJIFILM Irvine Scientific, Inc. engages in the manufacture and distribution of cell culture media, reagents, and medical devices. It offers bioproduction, assisted reproductive technology, cytogenetics, cell and gene therapy, and classical media. The company was founded in 1970 and is headquartered Santa Ana, CA. | Health Technology |
Viroblock SA
Viroblock SA Miscellaneous Commercial ServicesCommercial Services Viroblock SA develops and commercializes antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, human and avian such As influenzas, SARS virus and the AIDS virus. The company was founded by Donald F. H. Wallach in 2005 and is headquartered in Irvine, CA. | Commercial Services |
European University Portugal Centro de Estudos de Gestão SA | Consumer Services |
Ares Serono SA | Health Technology |
Roche Diagnostics AG
Roche Diagnostics AG Medical SpecialtiesHealth Technology Part of Novartis AG, Roche Diagnostics AG is a Swiss healthcare company committed to improving lives through innovative medicines and diagnostic tests. The company is based in Rotkreuz, Switzerland. Roche has been a pioneer in healthcare since its founding in 1896 and has helped millions of patients worldwide. | Health Technology |
Bachem Bioscience, Inc. | |
Wombat Capital Ltd.
Wombat Capital Ltd. Wombat Capital Markets LLC is a registered broker-dealer and member of FINRA and SIPC. The company offers cross-border investment banking and strategic advisory services to the pharmaceutical outsourcing, medical devices, and diagnostics industries. The company is based in New York, NY. | |
European University Foundation | Commercial Services |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Bachem Americas, Inc.
Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA. | Health Technology |
Protein Technologies, Inc.
Protein Technologies, Inc. Medical SpecialtiesHealth Technology Protein Technologies, Inc. engages in the design, manufacture and supply of solid phase synthesizers. The company was founded in 1985 and is headquartered in Tucson, AZ. | Health Technology |
New England Peptide, Inc.
New England Peptide, Inc. Chemicals: Major DiversifiedProcess Industries New England Peptide, Inc. designs and manufactures peptides, polyclonal antibodies, and monoclonal antibodies for drug and vaccine discovery organizations. Its products include TrypTides, bioactive peptides, amino acids and resins, peptide synthesis accessories, ME Kit Exosome isolation, SISCAPA assay reagents, and TrypRaws. The company was founded by Samuel A. Massoni and Jennifer L. Massoni in 1998 and is headquartered in Gardner, MA. | Process Industries |